Search
for
Sort by
Research 541–570 of 1000+
- Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
- Hypoxia in Cell Reprogramming and the Epigenetic Regulations
- Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers
- Differentiation of Human Pluripotent Stem Cells Into Definitive Endoderm Cells in Various Flexible Three-Dimensional Cell Culture Systems: Possibilities and Limitations
- Synergizing Science and Care for Folliculitis Healing by using Phyllanthus emblica
- Sulfatase inhibitors: a patent review
- Recent Progress in Prostaglandin F 2a Ethanolamide (Prostamide F2a) Research and Therapeutics
- Oil-in-Water型ナノエマルションに基づく局所経皮送達システムに関する研究
- Caractérisation physique et chimique des substances à activité thérapeutique : application aux études de profil de stabilité et de préformulation
- Hair follicle targeting with curcumin nanocrystals: Influence of the formulation properties on the penetration efficacy
- Zfp462 deficiency causes anxiety‐like behaviors with excessive self‐grooming in mice
- Squarticles as a nanocarrier for targeting minoxidil to hair follicles and dermal papilla cells
- GBP1 as a machine learning-prioritized biomarker and therapeutic target for epstein-barr virus-induced clear cell renal cell carcinoma: multi-omics causal validation
- Streptomyces-derived nano-doxorubicin: Clinical status and patents granted
- When two plus two must not equal four
- Assessing the cost-effectiveness of DNA origami nanostructures for targeted delivery of anti-cancer drugs to tumours
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Curly Hair: A Rare Side Effect of Sodium Valproate in a Child
- Structural Study of Polymorphs and Solvates of Finasteride
- Monocyclic Aromatic Compounds
- Discussion of “A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III” by Andrew G. Chapple and Peter F. Thall
- Clinical Pharmacokinetics and Pharmacodynamics of Finasteride
- Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post‐Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology
- Recent Progress in Prostaglandin F<sub>2</sub><i><sub>α</sub></i>Ethanolamide (Prostamide F<sub>2</sub><i><sub>α</sub></i>) Research and Therapeutics
- Effects of Fetal Exposure to Diazoxide in Man
- Rational Design and Synthesis of 4-((1<i>R</i>,2<i>R</i>)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications
- Three isostructural solvates of finasteride and their solid-state characterization
- New potential antiscarring approaches
- Expression analysis of proteasome maturation protein (<i>POMP</i>) gene in Liaoning Cashmere goat
- Chemistry of Cosmetics